![Marcus Irsfeld](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Marcus Irsfeld
Oprichter bij Artract Medical, Inc.
Momenteel actieve connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Wolfgang Gœtz | M | - |
Artract Medical, Inc.
![]() Artract Medical, Inc. Medical SpecialtiesHealth Technology Artract Medical, Inc. is a medical device company based in New York, NY. The company has developed a passive hemodynamic assist device called the Artract System, which is implanted percutaneously to treat heart failure with preserved ejection fraction (HFPEF). HFPEF is a complex clinical syndrome that results from any structural or functional impairment of ventricular filling or ejection of blood. The Artract System reduces shortness of breath, improves exercise tolerance, and reduces the need for daily medication and frequent hospital stays. The company was founded by Marcus Irsfeld and Wolfgang Gœtz. | 6 jaar |
Volker Berl | M | 51 |
Artract Medical, Inc.
![]() Artract Medical, Inc. Medical SpecialtiesHealth Technology Artract Medical, Inc. is a medical device company based in New York, NY. The company has developed a passive hemodynamic assist device called the Artract System, which is implanted percutaneously to treat heart failure with preserved ejection fraction (HFPEF). HFPEF is a complex clinical syndrome that results from any structural or functional impairment of ventricular filling or ejection of blood. The Artract System reduces shortness of breath, improves exercise tolerance, and reduces the need for daily medication and frequent hospital stays. The company was founded by Marcus Irsfeld and Wolfgang Gœtz. | 3 jaar |
Markus Frank | M | - |
Artract Medical, Inc.
![]() Artract Medical, Inc. Medical SpecialtiesHealth Technology Artract Medical, Inc. is a medical device company based in New York, NY. The company has developed a passive hemodynamic assist device called the Artract System, which is implanted percutaneously to treat heart failure with preserved ejection fraction (HFPEF). HFPEF is a complex clinical syndrome that results from any structural or functional impairment of ventricular filling or ejection of blood. The Artract System reduces shortness of breath, improves exercise tolerance, and reduces the need for daily medication and frequent hospital stays. The company was founded by Marcus Irsfeld and Wolfgang Gœtz. | 2 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Götz Münch | M | - |
ProCorde GmbH
![]() ProCorde GmbH Miscellaneous Commercial ServicesCommercial Services Founded in 2000,Precorde GmbH develops biotechnology for the integrated development of biomedical drugs in cardiovascular diseases. | - |
Statistieken
Land | Connecties | % van het totaal |
---|---|---|
Verenigde Staten | 3 | 75.00% |
Duitsland | 1 | 25.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Marcus Irsfeld
- Persoonlijk netwerk